Marcaine Adrenaline

Bupivacaine hydrochloride, the active ingredient in Marcaine Adrenaline, is a local anesthetic (amide) presented as an injectable solution for epidural, infiltration and intra‑articular use. It provides regional numbness for obstetric, surgical and joint procedures in adult patients.

GNH USA supplies Marcaine Adrenaline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring consistent quality and regulatory compliance for global healthcare providers. The company adheres to EU GMP standards and provides reliable cold‑chain logistics where required.

Marcaine Adrenaline is used for regional anesthesia in various procedural pathways.

Epidural anesthesia: provides prolonged numbness for obstetric deliveries and major surgical procedures, reducing the need for systemic analgesics. Infiltration anesthesia: delivers local pain control for minor surgical or diagnostic interventions, allowing precise anesthesia of targeted tissue while preserving motor function. Intra‑articular anesthesia: facilitates joint procedures such as arthroscopy or injection therapy by numbing the joint space, improving patient comfort and procedural efficiency.

Marcaine Adrenaline may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Transient pain at the injection site - Tachycardia - Hypertension - Nausea

Serious or Rare Side Effects: - Cardiac arrhythmias - Seizures - Methemoglobinemia

When using Marcaine Adrenaline, clinicians should observe several safety measures.

Dose determination: individualize based on patient age, weight, comorbidities and procedural requirements. Allergy assessment: verify no hypersensitivity to bupivacaine, epinephrine or other amide anesthetics. Cardiovascular monitoring: observe heart rate and blood pressure due to epinephrine effects. Use with caution in patients with hepatic impairment, as bupivacaine is metabolized hepatically. Avoid intravascular injection: aspirate before administration to prevent systemic toxicity. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Marcaine Adrenaline can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Beta‑blockers: may potentiate epinephrine‑induced hypertension and tachycardia. - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of bupivacaine cardiotoxicity. - MAO inhibitors: can enhance hypertensive response to epinephrine.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative toxicity risk if combined. - Calcium channel blockers: may affect cardiac conduction when combined with bupivacaine. - Tricyclic antidepressants: may lower seizure threshold with bupivacaine.